-
Deqi Pharmaceutical is included in Shenzhen-Hong Kong Stock Connect and Hong Kong Stock Connect
Time of Update: 2021-07-18
Only 4 months after listing, Deqi Pharmaceutical was selected into 9 benchmarks and thematic indexes including the Hang Seng Composite Index and included in Shenzhen-Hong Kong Stock Connect, which fully demonstrated the recognition of the company's strength and development potential by the capital market .
-
After losing the "Pig King" throne, he was overtaken by Wen's shares. Why
Time of Update: 2021-06-23
In response to the decline in performance, the relevant staff of Wen's shares told a reporter from China Business Daily at the end of 2020 that the sales price of live poultry fell sharply compared with the same period in previous years, and the profit of chicken and duck breeding business fell sharply year-on-year.
-
Fosun Pharma executives change
Time of Update: 2021-03-23
Li Dongjiu, born in March 1965, is currently the Senior Vice President of Fosun Pharma.
(stock code: 01099), a company listed on the Hong Kong Stock Exchange Director, Vice President and General Counsel of Sinopharm Holdings Co.
-
The first day of Anhui / Henan pig survey
Time of Update: 2020-06-19
As the largest animal husbandry variety in the world and the largest agricultural variety in China, the listing of pig futures will provide effective risk management tools for pig breeding en
-
Fosun Pharmaceutical publishes the global offering results
Time of Update: 2012-10-30
Source: Shanghai Fosun Pharmaceutical (Group) Co., Ltd has a final price of HK $11.8 per share on October 30, 2012 [Hong Kong news, October 29, 2012] Shanghai Fosun Pharmaceutical (Group), China's lea
